noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Carlsmed Inc.

Additional Proxy Soliciting Materials (Form DEFA14A)
American Bitcoin Corp.

American Bitcoin Completes Energization of ~11,298 Additional ASICs
Frost Brown Todd LLC

Kentucky General Assembly Lends Support for Nuclear Development with[...]

Healthcare

Jade Biosciences Inc.

04/22/2026 | Press release | Distributed by Public on 04/22/2026 05:19

Management Change/Compensation (Form 8-K)

Item 5.02.

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On April 18, 2026, the Board of Directors of Jade Biosciences, Inc. (the "Company") appointed Andrew King, BVMS, Ph.D. as the Company's President, Research & Development, effective as of April 18, 2026. Dr. King was previously the Company's Chief Scientific Officer and Head of Research & Development. No changes were made to Dr. King's compensation in connection with such appointment.

Jade Biosciences Inc. published this content on April 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on April 22, 2026 at 11:19 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]